Skip to content

Clinical study on the differential expression of circulating small extracellular vesicles derived miRNAs in lung cancer

Clinical study on the differential expression of circulating small extracellular vesicles derived miRNAs in lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062672
Enrollment
Unknown
Registered
2022-08-15
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

control group:Detection of the expression of circulating small extracellular vesicles derived miRNA
Small cell lung cancer group:Detection the expression of circulating small extracellular vesicles derived miRNAs
non-small cell lung cancer group:Detection the expression of circulating small extracellular vesicles derived miRNA

Sponsors

The Fourth Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. With the consent of the patient and signing the informed consent form, willing and able to comply with procedures such as blood collection and laboratory examination; 2. Patients aged 18-80 years (including the boundary value), both male and female; 3. Life expectancy >= 12 weeks; 4. Newly diagnosed patients with lung cancer after pathological examination; 5. The Eastern Cooperative Oncology Group (ECOG) score is 0 to 2; 6. At least one measurable lesion meeting RECIST 1.1 criteria; 7. There is a clear TNM staging; 8. No history of other tumors; 9. No infectious diseases; 10. No immune system disease.

Exclusion criteria

Exclusion criteria: 1. Failure to comply with the research protocol or research procedures; 2. Pneumonia patients with a history of tumors or lung cancer patients with a history of other tumors: 3. Those who have serious underlying diseases and unstable vital signs.

Design outcomes

Primary

MeasureTime frame
expression of circulating small extracellular vesicles derived miRNA;

Countries

China

Contacts

Public ContactPing Wang

The Fourth Hospital of Hebei Medical University

pingwang1393@163.com+86 13931130696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026